US Patent Issued to NantBio on Oct. 27 for "Methods of reducing epithelial-mesenchymal transition with an interleukin-8 antibody" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,328, issued on Oct. 27, was assigned to NantBio Inc. (Culver City, Calif.).

"Methods of reducing epithelial-mesenchymal transition with an interleukin-8 antibody" was invented by Patrick Soon-Shiong (Culver City, Calif.), Kayvan Niazi (Culver City, Calif.), Shiho Tanaka (Culver City, Calif.), Jon Thomas Van Lew (Culver City, Calif.), Clifford Anders Olson (Culver City, Calif.) and Philip T. Liu (Culver City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions, methods, and uses of recombinant IL-8 antibody, fragment thereof or single chain variable fragment (scFv) having high affinity to IL-8 to target tumor-expressed or endogenous IL...